BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35501460)

  • 1. RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer.
    Chen SY; Chen KL; Ding LY; Yu CH; Wu HY; Chou YY; Chang CJ; Chang CH; Wu YN; Wu SR; Hou YC; Lee CT; Chen PC; Shan YS; Huang PH
    Oncogene; 2022 May; 41(22):3162-3176. PubMed ID: 35501460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeb1 in Stromal Myofibroblasts Promotes
    Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
    Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m
    Du X; Cheng C; Yang Y; Fan B; Wang P; Xia H; Ni X; Liu Q; Lu L; Wei L
    Mol Carcinog; 2024 May; 63(5):962-976. PubMed ID: 38411298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
    Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
    Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
    Vincent DF; Yan KP; Treilleux I; Gay F; Arfi V; Kaniewski B; Marie JC; Lepinasse F; Martel S; Goddard-Leon S; Iovanna JL; Dubus P; Garcia S; Puisieux A; Rimokh R; Bardeesy N; Scoazec JY; Losson R; Bartholin L
    PLoS Genet; 2009 Jul; 5(7):e1000575. PubMed ID: 19629168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m
    Yang M; Wei R; Zhang S; Hu S; Liang X; Yang Z; Zhang C; Zhang Y; Cai L; Xie Y
    Cell Death Dis; 2023 Feb; 14(2):125. PubMed ID: 36792587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Wang N; Chen RX; Deng MH; Wei WS; Zhou ZH; Ning K; Li YH; Li XD; Ye YL; Wen JH; Dong B; Zhang XP; Liu ZW; Zhou FJ
    Cell Death Dis; 2023 Feb; 14(2):139. PubMed ID: 36806253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m
    Zhang X; An K; Ge X; Sun Y; Wei J; Ren W; Wang H; Wang Y; Du Y; He L; Li O; Zhou S; Shi Y; Ren T; Yang YG; Kan Q; Tian X
    Breast Cancer Res; 2024 Jun; 26(1):94. PubMed ID: 38844963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
    Wang Y; Wei J; Feng L; Li O; Huang L; Zhou S; Xu Y; An K; Zhang Y; Chen R; He L; Wang Q; Wang H; Du Y; Liu R; Huang C; Zhang X; Yang YG; Kan Q; Tian X
    Mol Cancer; 2023 May; 22(1):81. PubMed ID: 37161388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
    Hu Y; Chen C; Tong X; Chen S; Hu X; Pan B; Sun X; Chen Z; Shi X; Hu Y; Shen X; Xue X; Lu M
    Cell Death Dis; 2021 Sep; 12(9):842. PubMed ID: 34504059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
    Zou S; Huang Y; Yang Z; Zhang J; Meng M; Zhang Y; Feng J; Sun R; Li W; Wang W; López JG; Fang L
    Clin Transl Med; 2024 Mar; 14(3):e1621. PubMed ID: 38468490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization.
    Su J; Wu G; Ye Y; Zhang J; Zeng L; Huang X; Zheng Y; Bai R; Zhuang L; Li M; Pan L; Deng J; Li R; Deng S; Zhang S; Zuo Z; Liu Z; Lin J; Lin D; Zheng J
    Oncogene; 2021 Sep; 40(39):5814-5828. PubMed ID: 34345012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.